Please Scroll Down to See Forums Below
napsgear
genezapharmateuticals
domestic-supply
puritysourcelabs
UGL OZ
UGFREAK
napsgeargenezapharmateuticals domestic-supplypuritysourcelabsUGL OZUGFREAK

"DHT" in "Andractim" Gyno gel?...

  • Thread starter Thread starter bodytemple75
  • Start date Start date
B

bodytemple75

Guest
Read up on this and sounds good, but DHT makes your hair fall out. Does taking "Andractim" for gynocomastia reduction have any affect on your hair when you take it? DHT is listed as it's active ingred. or something like that...I mean..."Will it cause (your hair)it to fall out?" We all know DHT is responsible for all male pattern baldness. Not going bald here, have full head of hair,...but don't want to bald any time in future...(lol) Don't want to bring on anything that might be in far future possibly... I know gear instigates it, but different story though, process id different. Taking DHT straight...worried here..Getting your gyno under control under 5k is cool, but please....I need all of my hair. :) My thoughts...Help! Please,...I want to get my titties under a b cup, while keeping every inch of my hair on my scalp.
Andractim....I'm comming...


help is appreciated...worried...


thanks,

b o d y t e m p l e.
 
I don't think anyone knows how much DHT is going to end up circulating through your body and cause symptoms like hair loss. I would think the using topical DHT blockers on the scalp would help possible side effects of the cream.
 
ulter said:
It will shut down your LH and natural test so you can bet it will make your hair fall out. DHT is also thought to be the cause of prostate cancer, which if you're an AIDS patient isn't a big deal. I still think this is a bid mistake for people to use this stuff.

ha! found this one. not getting away with it this time! how the hell can a topical (and light topical at that if you put a light layer on) circulate enough DHT into the system to cause any kinds of problems? i mean i am taking nizoral/spiro/AAcid/minoxidil/proscar or Sawpalmetto.......so i am quite a bit more ready to battle extra DHT than the average dude.......but could the minimal amount in the gel really have any harmful effect? and if so, just go buy some SP extract and boatload it in.......and put some topicals on your scalp. worth it to combat the sides if the gel works like it should.
 
DHT is also thought to be the cause of prostate cancer, which if you're an AIDS patient isn't a big deal. I still think this is a bid mistake for people to use this stuff.

If I were an AIDS patient I would be pretty pissed off to hear that kind of talk, as if I wouldn't be concerned about cancer. It is also contrary to the results of studies of DHT gel.


"The effects of 3 months of DHT treatment on the prostate in this study were minimal or even potentially beneficial, because there was no evidenceof stimulatory effects on prostate volumes or PSA concen-trations. Indeed, the underlying tendency toward prostate volume growth in older men, as evident in the placebo-treated group, was absent in the DHT-treated men. This raises the possibility that DHT treatment, because of its inability to exhibit intraprostatic amplification, has less selective prostate growth effects than would T."

The above was part of the conclusion of the study whose abstract is reproduced below:

J Clin Endocrinol Metab 2001 Sep;86(9):4078-88

A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency.

Ly LP, Jimenez M, Zhuang TN, Celermajer DS, Conway AJ, Handelsman DJ.

Department of Andrology, Concord Hospital, Concord, New South Wales 2139, Australia.

The efficacy and safety of androgen supplementation in older men remains controversial. Despite biochemical evidence of partial androgen deficiency in older men, controlled studies using T demonstrate equivocal benefits. Furthermore, the importance of aromatization and 5alpha reduction in androgen actions among older men remains unclear. Dihydrotestosterone is the highest potency natural androgen with the additional features that it is neither aromatizable nor susceptible to potency amplification by 5alpha reduction. Therefore, the effects of dihydrotestosterone may differ from those of T in older men. This study evaluated the efficacy and safety of 3 months treatment with transdermal dihydrotestosterone gel on muscle strength, mobility, and quality of life in ambulant, community-dwelling men aged 60 yr or older. Eligible men (plasma T < or =15 nmol/liter) were randomized to undergo daily dermal application of 70 mg dihydrotestosterone gel (n = 18) or vehicle (n = 19) and were studied before, monthly during, and 1 month after treatment. Among 33 (17 dihydrotestosterone, 16 placebo) men completing the study with a high degree of compliance, dihydrotestosterone had significant effects on circulating hormones (increased dihydrotestosterone; decreased total and free testosterone, LH, and FSH; unchanged SHBG and estradiol), lipid profiles (decreased total and low-density lipoprotein cholesterols; unchanged high-density lipoprotein cholesterol and triglycerides), hematopoiesis (increased hemoglobin, hematocrit, and red cell counts), and body composition (decreased skinfold thickness and fat mass; unchanged lean mass and waist to hip ratio). Muscle strength measured by isokinetic peak torque was increased in flexion of the dominant knee but not in knee extension or shoulder contraction, nor was there any significant change in gait, balance, or mobility tests, in cognitive function, or in quality of life scales. Dihydrotestosterone treatment had no adverse effects on prostate (unchanged prostate volumes and prostate-specific antigen) and cardiovascular (no adverse change in vascular reactivity or lipids) safety markers. We conclude that 3 months treatment with transdermal dihydrotestosterone gel demonstrates expected androgenic effects, short-term safety, and limited improvement in lower limb muscle strength but no change in physical functioning or cognitive function.
 
nandi12 said:


If I were an AIDS patient I would be pretty pissed off to hear that kind of talk, as if I wouldn't be concerned about cancer. It is also contrary to the results of studies of DHT gel.


"The effects of 3 months of DHT treatment on the prostate in this study were minimal or even potentially beneficial, because there was no evidenceof stimulatory effects on prostate volumes or PSA concen-trations. Indeed, the underlying tendency toward prostate volume growth in older men, as evident in the placebo-treated group, was absent in the DHT-treated men. This raises the possibility that DHT treatment, because of its inability to exhibit intraprostatic amplification, has less selective prostate growth effects than would T."

The above was part of the conclusion of the study whose abstract is reproduced below:

J Clin Endocrinol Metab 2001 Sep;86(9):4078-88

A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency.

Ly LP, Jimenez M, Zhuang TN, Celermajer DS, Conway AJ, Handelsman DJ.

Department of Andrology, Concord Hospital, Concord, New South Wales 2139, Australia.

The efficacy and safety of androgen supplementation in older men remains controversial. Despite biochemical evidence of partial androgen deficiency in older men, controlled studies using T demonstrate equivocal benefits. Furthermore, the importance of aromatization and 5alpha reduction in androgen actions among older men remains unclear. Dihydrotestosterone is the highest potency natural androgen with the additional features that it is neither aromatizable nor susceptible to potency amplification by 5alpha reduction. Therefore, the effects of dihydrotestosterone may differ from those of T in older men. This study evaluated the efficacy and safety of 3 months treatment with transdermal dihydrotestosterone gel on muscle strength, mobility, and quality of life in ambulant, community-dwelling men aged 60 yr or older. Eligible men (plasma T < or =15 nmol/liter) were randomized to undergo daily dermal application of 70 mg dihydrotestosterone gel (n = 18) or vehicle (n = 19) and were studied before, monthly during, and 1 month after treatment. Among 33 (17 dihydrotestosterone, 16 placebo) men completing the study with a high degree of compliance, dihydrotestosterone had significant effects on circulating hormones (increased dihydrotestosterone; decreased total and free testosterone, LH, and FSH; unchanged SHBG and estradiol), lipid profiles (decreased total and low-density lipoprotein cholesterols; unchanged high-density lipoprotein cholesterol and triglycerides), hematopoiesis (increased hemoglobin, hematocrit, and red cell counts), and body composition (decreased skinfold thickness and fat mass; unchanged lean mass and waist to hip ratio). Muscle strength measured by isokinetic peak torque was increased in flexion of the dominant knee but not in knee extension or shoulder contraction, nor was there any significant change in gait, balance, or mobility tests, in cognitive function, or in quality of life scales. Dihydrotestosterone treatment had no adverse effects on prostate (unchanged prostate volumes and prostate-specific antigen) and cardiovascular (no adverse change in vascular reactivity or lipids) safety markers. We conclude that 3 months treatment with transdermal dihydrotestosterone gel demonstrates expected androgenic effects, short-term safety, and limited improvement in lower limb muscle strength but no change in physical functioning or cognitive function.

all well and good.. however the point (with respect to use a "gyno" gel) is that the effects are systemic..

actually with respect to prostate cancer Estrogen is more heavily implicated (though this is still in dispute)..

though agree that aids patients should be as concerned as anyone about any type of cancer , perticularly since many are immuno comprimised (and given the fact that existing cocktail treatments can in many cases take blood levels to undectable levels.. a "temporary" cure)
 
all well and good.. however the point (with respect to use a "gyno" gel) is that the effects are systemic..


Exactly. It is the local conversion of testosterone to DHT within the prostate that may contribute to prostatic hyperplasia and possibly cancer. Likewise it is the local conversion of testosterone to DHT within the skin and scalp that contributes to alopecia and acne. As the study demonstrates, systemic DHT has no effect on the prostate, or a beneficial one by virtue of reduction of test that would otherwise be converted to DHT within the prostate.
 
Top Bottom